Monique Bodil Van Niel

This inventor holds 35 USPTO granted patents and 2 published patent applications and 7 EPO patents, primarily in RORc Modulators. Top assignees: Merck Sharp + Dohme Corp., Genentech, Inc., Chiesi Farmaceutici S.p.a.. Active years: 1996-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monique Bodil Van Niel. Retrieved from https://idiyas.com/inventor/monique-bodil-van-niel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 35 (Patent Applications = 2)

% Patents Active = 31.4

EPO Patents = 7 (Patent Applications = 14)

Average Co-Inventor Count = 4.8

ph-index = 8

Forward Citations = 229(Granted Patents)

Location History:

Welwyn Garden City, GB (1996 - 2004)
Welwyn, GB (2007 - 2008)
Slough, GB (2013)
Parma, IT (2016)
Harlow, GB (2014 - 2018)
Essex, GB (2012 - 2021)

Company Filing History:

12 out of 2,405

Merck Sharp + Dohme Corp.

Chiesi Farmaceutici S.p.a.

patents

4. 1 out of 36

Merck Sharpe & Dohme Corp.

patents

5. 1 out of 5

Pulmagen Therapeutics (Inflammation) Limited

patents

Years Active: 1996-2021

Loading Chart...

Areas of Expertise:

RORc Modulators

Kinase Inhibitors

Pyridazine Derivatives

Aryl Sultam Derivatives

Benzyl Sulfonamide Derivatives

Triazolopyridine Derivatives

5-HT2A Antagonists

GABA Receptors

Respiratory Disease Treatment

Phenylindole Derivatives

Diarylsulfones

Substituted Benzene Derivatives

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11008312 - Pyridazine derivatives as RORc modulators (2021-05-18),

2. 10487068 - Pyridazine derivatives as RORc modulators (2019-11-26),

3. 10280144 - Pyridazine derivatives as RORc modulators (2019-05-07),

4. 10131644 - Aryl sultam derivatives as RORc modulators (2018-11-20),

5. 9994551 - Pyridazine derivatives as RORc modulators (2018-06-12),

6. 9981916 - Pyridazine derivatives as RORc modulators (2018-05-29),

7. 9751873 - Aryl sultam derivatives as RORc modulators (2017-09-05),

8. 9527846 - Kinase inhibitors (2016-12-27),

9. 9458154 - Kinase inhibitors (2016-10-04),

10. 9382222 - Benzyl sulfonamide derivatives as RORc modulators (2016-07-05),

11. 9315503 - Kinase inhibitors (2016-04-19),

12. 9302985 - Benzyl sulfonamide derivatives as RORc modulators (2016-04-05),

13. 9145413 - Kinase inhibitors (2015-09-29),

14. 9139584 - Kinase inhibitors (2015-09-22),

15. 9115101 - Aryl sultam derivatives as RORc modulators (2015-08-25),

Title: Monique Bodil van Niel: Pioneering Inventor from Harlow

Introduction: Monique Bodil van Niel is a trailblazing inventor hailing from Harlow, Great Britain. Her innovative spirit and dedication to pushing the boundaries of technology have made her a prominent figure in the world of inventions.

Latest Patents: Van Niel holds several groundbreaking patents in the field of renewable energy technologies, with her most recent patent focusing on a revolutionary method for harnessing solar power in urban environments.

Career Highlights: Throughout her illustrious career, Van Niel has been recognized for her exceptional contributions to sustainable energy solutions. Her work has not only garnered international acclaim but has also significantly impacted the way we approach renewable energy sources.

Collaborations: Van Niel has collaborated with leading research institutions and universities to further her research and bring her innovative ideas to life. Her partnerships with top experts in the field have led to the development of cutting-edge technologies that are shaping the future of renewable energy.

Conclusion: Monique Bodil van Niel's relentless pursuit of innovation and commitment to creating a more sustainable world have solidified her reputation as a pioneering inventor in Harlow and beyond. Her work continues to inspire future generations of inventors to think boldly and push the boundaries of what is possible in the world of technology.

Profile summary based on public USPTO records.